Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Neither person did anything careless
The most common adverse events were gastrointestinal and primarily mild to moderate in severity in the tirzepatide and semaglutide groups
PMID: 21 WangCChenZYiYDingYXuFKangHet al
The SURMOUNT-1 trial enrolled 2,539 patients with obesity, excluding individuals with diabetes or uncontrolled hypertension, and randomized them to placebo or 5, 10, or 15 mg of tirzepatide
US$ 29.63
US$ 28.09
US$ 28.16
US$ 26.26
US$ 22.28
US$ 25.74
